Although the benchmark indices opened flat, they traded negatively throughout the session and ultimately closed red.
Indian equity benchmarks, Sensex and Nifty50, settled lower as bank and financial stocks weighed, while traders navigated the tricky geopolitical situation amid uncertainty over the US-Iran deal.
Please note that markets will remain closed on Thursday, 28 May 2025, on the occasion of Eid.
At the closing bell, the BSE Sensex closed 142 points lower (down 0.1%)
Meanwhile, the NSE Nifty closed 6 points lower
Eternal, NTPC, Tata Steel were the top gainers today.
HDFC Bank, ICICI Bank, ITC on the other hand, were among the top losers today.
The GIFT Nifty was trading at 23,962 with 50 points higher at the time of writing.
The BSE 150 Midcap index is trading 0.8% higher, and the BSE 250 SmallCap index is trading 0.4% higher.
Sectoral indices were trading positively today, with the banking and IT sector witnesses selling pressure. Meanwhile, stocks in the metal sector and the auto sector witness buying.
The rupee is trading at Rs 95.7 against the US$.
Gold prices for the latest contract on MCX are trading 0.4% lower at Rs 1,56,976 per 10 grams.
Meanwhile, silver prices were trading 0.8% lower at 2,68,341 per 1 kg.
Procter & Gamble Health Q4 FY26 Results
Shares of Procter & Gamble Health came into focus after the company reported its Q4 FY26 results.
P&G Health reported a strong performance for Q4 FY26, with net profit rising 56% YoY to Rs 0.95 bn compared to Rs 0.61 bn in the corresponding quarter last year. The company said growth was driven by superior brand-building initiatives along with strengthened supply chain and go-to-market capabilities.
Revenue from operations increased 19% YoY to Rs 3.7 bn during the January-March quarter, compared to Rs 3.11 bn in the year-ago period.
At the operating level, EBITDA rose 67% YoY to Rs 1.35 bn from Rs 0.81 bn a year earlier. EBITDA margin expanded sharply to 36.6% from 26% in the corresponding quarter last year.
The board has also recommended a final dividend of Rs 45 per equity share for FY26, subject to shareholder approval at the upcoming AGM.
Finolex Industries Q4 FY26 Results
Shares of Finolex Industries came into focus after the company reported its Q4 FY26 results.
Finolex Industries reported a strong Q4 FY26 performance, with consolidated net profit rising 59% YoY to Rs 2.61 bn compared to Rs 1.65 bn in the corresponding quarter last year.
Revenue from operations increased 12% YoY to Rs 13.14 bn during the quarter, primarily driven by better realizations, compared to Rs 11.72 bn reported in Q4 FY25.
EBITDA for the quarter surged to Rs 3.32 bn from Rs 1.71 bn in the year-ago period, while EBITDA margin expanded significantly to 25% from 15%.
The company reported largely stable volumes during the quarter at 101,772 MT, compared to 102,253 MT in the March quarter of FY25.
Gujarat Fluorochemicals Q4 FY26 Results
Shares of Gujarat Fluorochemicals came into focus after the company reported its Q4 FY26 results.
Gujarat Fluorochemicals reported revenue from operations of Rs 13.69 bn in Q4 FY26, marking a 12% YoY increase compared to Rs 12.55 bn in the corresponding quarter last year.
EBITDA for the quarter rose marginally to Rs 3.08 bn from Rs 3.06 bn in Q4 FY25. However, EBITDA margin contracted to 22% from 25% in the year-ago period.
Profit after tax (PAT) declined 32% YoY to Rs 1.12 bn during the quarter, compared to Rs 1.62 bn reported in the same period last fiscal.
The board has also recommended a final dividend of Rs 3 per equity share for FY26, subject to shareholder approval at the upcoming AGM.
Comments
Log in or sign up to join the conversation.